HRP20190589T1 - Antimalarijski spojevi sa fleksibilnim bočnim-lancima - Google Patents

Antimalarijski spojevi sa fleksibilnim bočnim-lancima Download PDF

Info

Publication number
HRP20190589T1
HRP20190589T1 HRP20190589TT HRP20190589T HRP20190589T1 HR P20190589 T1 HRP20190589 T1 HR P20190589T1 HR P20190589T T HRP20190589T T HR P20190589TT HR P20190589 T HRP20190589 T HR P20190589T HR P20190589 T1 HRP20190589 T1 HR P20190589T1
Authority
HR
Croatia
Prior art keywords
compound
substituted
diamino
propoxy
compound according
Prior art date
Application number
HRP20190589TT
Other languages
English (en)
Croatian (hr)
Inventor
Yongyuth Yuthavong
Tirayut Vilaivan
Sumalee Kamchonwongpaisan
Bongkoch Tarnchompoo
Chawanee Thongpanchang
Penchit Chitnumsub
Jirundon Yuvaniyama
David Matthews
Susan Charman
William Charman
Livia Vivas
Sanjay Babu Katiyar
Original Assignee
Mmv Medicines For Malaria Venture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mmv Medicines For Malaria Venture filed Critical Mmv Medicines For Malaria Venture
Publication of HRP20190589T1 publication Critical patent/HRP20190589T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20190589TT 2007-10-08 2008-10-08 Antimalarijski spojevi sa fleksibilnim bočnim-lancima HRP20190589T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97837507P 2007-10-08 2007-10-08
EP08837766.8A EP2194985B1 (en) 2007-10-08 2008-10-08 Antimalarial compounds with flexible side-chains
PCT/US2008/079210 WO2009048957A1 (en) 2007-10-08 2008-10-08 Antimalarial compounds with flexible side-chains

Publications (1)

Publication Number Publication Date
HRP20190589T1 true HRP20190589T1 (hr) 2019-05-31

Family

ID=40534843

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190589TT HRP20190589T1 (hr) 2007-10-08 2008-10-08 Antimalarijski spojevi sa fleksibilnim bočnim-lancima

Country Status (22)

Country Link
US (1) US8530491B2 (enExample)
EP (2) EP3546452A1 (enExample)
JP (1) JP5603775B2 (enExample)
KR (1) KR101578949B1 (enExample)
CN (1) CN101820879B (enExample)
AU (1) AU2008310898B2 (enExample)
BR (1) BRPI0818618B8 (enExample)
CA (1) CA2700880C (enExample)
CY (1) CY1121598T1 (enExample)
DK (1) DK2194985T3 (enExample)
ES (1) ES2727015T3 (enExample)
HR (1) HRP20190589T1 (enExample)
HU (1) HUE044398T2 (enExample)
LT (1) LT2194985T (enExample)
MX (1) MX2010003739A (enExample)
PL (1) PL2194985T3 (enExample)
PT (1) PT2194985T (enExample)
RU (1) RU2485107C2 (enExample)
SI (1) SI2194985T1 (enExample)
TR (1) TR201904913T4 (enExample)
UA (1) UA105759C2 (enExample)
WO (1) WO2009048957A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012108845A1 (en) * 2011-02-09 2012-08-16 National Science And Technology Development Agency A bacterial surrogate for testing of antimalarials: thya knockout and fola knockout bacteria for testing of inhibition of malarial dihydrofolate reductase-thymidylate synthase
US9000003B2 (en) * 2011-03-10 2015-04-07 National Science And Technology Development Agency Anti-folate antimalarials with dual-binding modes and their preparation
WO2015047199A2 (en) 2013-09-30 2015-04-02 National Science And Technology Development Agency A bacterial surrogate for testing of antimalarials: thya knockout, fola knockout, folp knockout, and folk knockout bacteria for testing of inhibition of antifolate pathway
CN104593406A (zh) * 2015-01-08 2015-05-06 山西医科大学 pIRES/TgDHFR-TS真核表达重组质粒及其构建和应用
WO2017052479A1 (en) * 2015-09-23 2017-03-30 National Science And Technology Development Agency 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against plasmodium falciparum
CN106083742A (zh) * 2016-05-31 2016-11-09 广东工业大学 一种2,4‑二胺基喹唑啉衍生物及其制备方法和应用
WO2021155748A1 (en) * 2020-02-04 2021-08-12 Tsinghua University Inhibitors of malarial and plasmodium falciparum hexose transporter and uses thereof
CN112961106A (zh) * 2021-03-13 2021-06-15 德州学院 一种4-羟基-6氯喹啉合成新工艺
EP4438596A1 (en) * 2023-03-28 2024-10-02 Université de Lille Diaminopyrimidine derivatives as hdac and dhfr dual-targeting inhibitors and use thereof in preventing and treating malaria
WO2025053796A1 (en) * 2023-09-04 2025-03-13 National Science And Technology Development Agency Hybrid molecules between pyrimidine derivatives and idasanutlin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
GB1546937A (en) * 1976-07-29 1979-05-31 Beecham Group Ltd 2,4-diaminopyrimidine derivatives
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
OA07362A (fr) * 1980-10-27 1984-06-30 May & Baker Ltd Dérivés de la pyrimidine, leur procédé de préparation et les compositions les contenant.
GB2086386B (en) 1980-10-27 1984-01-18 May & Baker Ltd Pyrimidine derivatives
US5322858A (en) 1992-02-14 1994-06-21 Jacobus Pharmaceutical Co. Inc. N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
RU95113597A (ru) 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
HK1042049A1 (en) 1999-05-24 2002-08-02 Sankyo Company, Limited Medicinal compositions containing anti-fas antibody
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them

Also Published As

Publication number Publication date
TR201904913T4 (tr) 2019-05-21
JP5603775B2 (ja) 2014-10-08
WO2009048957A1 (en) 2009-04-16
CY1121598T1 (el) 2020-07-31
WO2009048957A8 (en) 2010-04-22
RU2485107C2 (ru) 2013-06-20
ES2727015T3 (es) 2019-10-11
EP2194985A1 (en) 2010-06-16
HUE044398T2 (hu) 2019-10-28
CA2700880A1 (en) 2009-04-16
AU2008310898A1 (en) 2009-04-16
PL2194985T3 (pl) 2019-12-31
EP2194985A4 (en) 2012-01-25
BRPI0818618A2 (pt) 2015-08-04
KR101578949B1 (ko) 2015-12-18
JP2010540666A (ja) 2010-12-24
SI2194985T1 (sl) 2019-04-30
CA2700880C (en) 2016-03-08
LT2194985T (lt) 2019-04-10
PT2194985T (pt) 2019-05-30
RU2010117193A (ru) 2011-11-20
EP3546452A1 (en) 2019-10-02
US20090099220A1 (en) 2009-04-16
MX2010003739A (es) 2010-04-21
CN101820879A (zh) 2010-09-01
UA105759C2 (uk) 2014-06-25
BRPI0818618B1 (pt) 2020-03-03
AU2008310898B2 (en) 2014-05-08
KR20100094459A (ko) 2010-08-26
EP2194985B1 (en) 2019-02-20
DK2194985T3 (da) 2019-05-20
US8530491B2 (en) 2013-09-10
CN101820879B (zh) 2013-01-02
BRPI0818618B8 (pt) 2023-04-25

Similar Documents

Publication Publication Date Title
HRP20190589T1 (hr) Antimalarijski spojevi sa fleksibilnim bočnim-lancima
CY1124503T1 (el) Βοριοφθαλιδια για θεραπευτικη χρηση
JP2017513836A5 (enExample)
JP2010508296A5 (enExample)
RU2013119966A (ru) Композиция, улучшающая растворимость плохорастворимого лекарственного препарата
HRP20130846T1 (hr) Derivati indolizina i njihova uporaba u medicinske svrhe
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
JP2010503688A5 (enExample)
ME02675B (me) Novi derivati cikloheksilamina sa aktivnostima beta2 adrenergijskog agonista i m3 muscarinskog antagonista
WO2011089529A4 (en) Salicylate fatty acid derivatives
JP2005500363A5 (enExample)
CA2513092A1 (en) Compounds for the treatment of metabolic disorders
HRP20130041T1 (hr) Terapijska sredstva
JP2007502263A5 (enExample)
JP2010522710A5 (enExample)
ME02576B (me) Derivati tetrahidropirolotiazina kao inhibitori bace
JP2014505017A5 (enExample)
CA2521621A1 (en) Compounds for the treatment of metabolic disorders
AU2003228593B2 (en) Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
EE05035B1 (et) 1-[fenüül-(8-kinolinüül)metüül]piperasiini derivaadid ning nende kasutamine meditsiinis
RU2005114373A (ru) Хиральные производные оксазоларилпропионовой кислоты и их применение в качестве агонистов рецепторов, активированных пролифератором пароксисомы (ppar агонистов)
JP2013506703A5 (enExample)
ME02385B (me) Sulfonamidi za prevenciju dijabetesa
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
JP2019518029A5 (enExample)